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Evidence that complex traits are highly polygenic has been presented by population-based genome-wide association studies (GWASs)
through the identification of many significant variants, as well as by family-based de novo sequencing studies indicating that several
traits have a large mutational target size. Here, using a third study design, we show results consistent with extreme polygenicity for
body mass index (BMI) and height. On a sample of 20,240 siblings (from 9,570 nuclear families), we used a within-family method to
obtain narrow-sense heritability estimates of 0.42 (SE ¼ 0.17, p ¼ 0.01) and 0.69 (SE ¼ 0.14, p ¼ 6 3 107) for BMI and height, respec-
tively, after adjusting for covariates. The genomic inflation factors from locus-specific linkage analysis were 1.69 (SE¼ 0.21, p¼ 0.04) for
BMI and 2.18 (SE ¼ 0.21, p ¼ 2 3 1010) for height. This inflation is free of confounding and congruent with polygenicity, consistent
with observations of ever-increasing genomic-inflation factors from GWASs with large sample sizes, implying that those signals are due
to true genetic signals across the genome rather than population stratification.We also demonstrate that the distribution of the observed
test statistics is consistent with both rare and common variants underlying a polygenic architecture and that previous reports of linkage
signals in complex traits are probably a consequence of polygenic architecture rather than the segregation of variants with large effects.
The convergent empirical evidence from GWASs, de novo studies, and within-family segregation implies that family-based sequencing
studies for complex traits require very large sample sizes because the effects of causal variants are small on average.Introduction
Widely regarded as a growing epidemic,1 obesity is known
to be a precursor to social2,3 and psychological4 problems,
as well as a plethora of physiological conditions.5 Manag-
ing such a problem requires knowledge of the genetic
and environmental contributors to the disease. Body
mass index (BMI), a commonly used proxy for quantifying
obesity, predicts the risk of consequential etiology.6 In
addition to accurately estimating the heritability ðh2Þ of
BMI, understanding the genetic architecture that belies
genetic variation is also ofmajor importance for gene-map-
ping strategies, drug development, epidemiology, and the
future of genomic medicine. In this paper, we infer the
genetic architecture of BMI and height through calculating
heritability, the relative contribution of rare and common
variants, and the extent to which these traits are polygenic.
Crucially, we make inferences by using within-family
identity-by-descent (IBD) estimation because methods
using this framework are neither prone to confounding
due to population stratification nor dependent upon
strong modeling assumptions.
One reason that knowledge of a trait’s underlying
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Clues about the relative contribution of rare and common
variants can be leveraged from information between esti-
mates of h2 and the estimation of ‘‘chip heritability’’ (h2C,
the proportion of phenotypic variation captured by SNPs
on a SNP chip). The chip heritability of BMI is estimated
to be much lower for BMI ðh2C ¼ 0:17Þ 7 than for height
ðh2C ¼ 0:45Þ.7–10 Supposing that BMI and height had simi-
larly large true heritabilities (as is often shown from twin
studies),11,12 given that SNP chips capture the effects of
common variants better than the effects of rare variants,8
we might infer a larger contribution of rare variants influ-
encing BMI. However, previous heritability estimates for
BMI have varied enormously.13 Indeed, based on a recent
review,11 a meta-analysis of 81 twin studies led to an esti-
mate of 0.75, whereas a meta-analysis of 25 non-twin fam-
ily-based studies, performed on sample sizes in the low
thousands, gave an estimate of 0.46. Conversely, with esti-
mates typically in the range of 0.7–0.9, pedigree studies on
the heritability of height are more consistent with twin-
based studies.12,14
To date, far more variants have been discovered to be
robustly associated with height than with BMI, even
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possible explanation for this is a difference in heritability.
For example, if we assume the same number of genetic var-
iants for both traits, the average effect size will be smaller
in BMI if its heritability is lower, and therefore power will
be reduced for the same sample size. Power is proportional
to the square of the effect size, so if effect sizes are on
average halved, then four times the sample size is required
for detection. Alternatively, causal variants for BMI could
be at lower frequencies in the population than those for
height, also leading to decreased power in genome-wide
association studies (GWASs) as a result of reduced linkage
disequilibrium (LD) between causal variants and geno-
typed SNPs. It is important to distinguish between
these hypotheses because it quantifies howmuch variation
has not yet been accounted for by past experimental
designs.
Here, using amethod developed to avoid dependence on
modeling assumptions regarding between-family variance
by using the realized genetic sharing between siblings17 to
estimate heritability, we report heritability estimates of
0.42 for BMI and 0.69 for height on a sample of 20,240
quasi-independent sibling pairs (QISPs). This is at the lower
end of the scale of previous estimates and is consistent
with estimates resulting from family-based studies. Using
within-family IBD methods, we also demonstrate, while
being agnostic about allele frequencies, that there is strong
evidence of extreme polygenicity in BMI and height.
We demonstrate how the consequence of this finding
can explain why linkage analyses of complex traits over
the past two decades seldom replicate.18,19 Finally, we use
these data to provide empirical evidence that genomic
inflation (the overall elevation of test statistics across all
loci) increases with increased sample size as a result of
polygenic variation. This is an important finding that fore-
casts that, even after adequate correction for population
stratification, genomic inflation in very large association
studies is likely to occur when real genetic signals are
enriched as a result of increasing power with increasing
sample size.15
Material and Methods
Genotyping and Phenotyping
From five separate cohorts, we collected 20,240 QISPs who had
data on dense (minimum 300,000) SNP genotypes, height mea-
surements, weight measurements, age at time of measurements,
and gender. The term ‘‘quasi-independent’’ refers to the fact that
although there was often more than one sibling pair per family,
each sibling pair was treated as independent. Extensive descrip-
tions of each cohort have been provided previously, and they are
summarized in Table S1, available online. In brief, we obtained
9,585 QISPs from the Queensland Institute of Medical Research
(QIMR),20 4,607 from the Framingham Heart Study,21 2,722
from the Swedish Twin Registry’s TWINGENE data set,22,23 1,819
from the Netherland Twin Registry,24,25 and 1,507 from the UK
Twin Registry’s TWINSUK data set.26
All individuals in the study were of European ancestry and over
the age of 18 years old. BMI and height were adjusted with a linear866 The American Journal of Human Genetics 93, 865–875, Novembmodel for a number of covariates (see Table S2). BMI was also
adjusted for between-sex variance. Clinical or self-reported mea-
surements of height and weight were used for calculating BMI
by means of the standard formula of raw weight values (kg) over
the square of raw height values (m). The data-collection proce-
dures followed were in accordance with the ethical standards of
the respective responsible committees on human experimenta-
tion (institutional and national), and proper informed consent
was obtained.
Heritability Estimates
Marker-level IBD was calculated for each QISP with the Merlin
software package27 (see volta plots, Figure S1). For each of the
five cohorts, we selected full siblings and dizygotic twins and
pruned SNPs so that LD was constrained to r2 < 0.05 to ensure
that markers used for estimating IBD were in linkage equilibrium.
Minor allele frequency was greater than 0.2 for maximizing
information from the retained SNPs, leaving approximately
20,000 SNPs per cohort (Table S1). As can be seen in Figure S1,
this SNP density was sufficiently high to produce accurate
estimates of IBD. Subsequently, chromosome-wide IBD was calcu-
lated by approximate integration over the marker-wise IBD status
for all markers across a chromosome on the basis of their genetic
position:
q^j ¼
Xi¼1
i%m
1
2
di;iþ1ðxi þ xiþ1Þ;
where di;iþ1 is the genetic distance between marker i and iþ 1 and
xi is the estimate of IBD status at marker i.
Subsequently, genome-wide IBD, q^, was estimated as
q^ ¼ 1
L
Xj¼1
j%22
ljq^j;
where lj is the genetic length of chromosome j and L ¼
P
lj. The
genome-wide IBD matrix between QISPs was constructed as a
block diagonal 2n 3 2nmatrix (A), where n is the number of QISPs,
and each block was a 2 3 2 diagonal matrix with off-diagonal ele-
ments being qi coefficients for the i
th QISP. The common-environ-
ment matrix (C) was also 2n3 2n with 2 3 2 diagonal blocks
whose off-diagonal elements fixed to 1. The phenotype was then
modeled with linear mixed models of the form
y ¼ Xbþ g þ w þ e;
where y is the vector of phenotypes, X is the designmatrix of fixed
effects, b is the estimate of fixed effects, g is the vector of genetic
values, w is the vector of common environmental effects, and
e is the vector of residual values. The genetic variance was calcu-
lated as s2A ¼ varðgÞ and h2 ¼ s2A=s2P, where s2P is the phenotypic
variance. The partitioning of heritability estimates across
chromosomes was achieved by the construction of genetic-rela-
tionship matrices ðAjÞ for each chromosome ðjÞ from chromo-
some-wide IBD estimates ðq^jÞ and then via a joint analysis of
the form
y ¼ Xbþ
Xj¼1
j%22
gj þ w þ e:
These variance components can be calculated in 22 separate
models or in a single model comprising 22 componentser 7, 2013
(each model also fits C). The correlation between the h2 estimates
of each chromosome from these two approaches was high (r ¼
0.98), as would be expected given that the chromosome-
wide IBD values were uncorrelated. All restricted maximum likeli-
hood (REML) estimates were performed with the GCTA software
package.28
Simplifying the sibling relationship structure into QISPs instead
of having a block diagonal structure where each block represents
the siblings in one family is computationally more efficient with
the use of very large sample sizes and has now been implemented
as an option (–reml-wfam) in GCTA. Using simulation, we showed
that the estimates remain unbiased (Figure S2).
Linkage Analysis
IBD estimates at a 0.1 cM grid were obtained for each sibling pair
with the Merlin software package,27 and linkage analysis was
performed directly from these estimates. We used the Visscher-
Hopper (VH) method29,30 to regress IBD estimates because it is a
good approximation of themaximum-likelihood variance-compo-
nent method implemented in Merlin (Figure S3). In brief, the VH
method performs a within-locus meta-analysis for linkage tests
performed with two orthogonal similarity metrics, the sum of
squares of the difference in phenotypes, and the sum of squares
of the sum of phenotypes between the siblings. Because it has
been demonstrated to improve power in linkage analysis,31 246
and 254QISPs were excluded for having pD > pD þ 4SDðpDÞ, where
pD is the squared difference of the sibling phenotypes, for BMI and
height, respectively.
Meta-analysis
The linkage analysis can be performed as described above with
the use of all 20,240 QISPs or via a meta-analysis from the
summary statistics of linkage analyses performed on each cohort
separately. For a particular genetic position, the effect can be
calculated as
bM ¼
P bk
s2
kP
1
s2
k
;
for which the SE is
sM ¼ 1P 1
sk
;
where k ¼ f1.5g represents each cohort. The strong correla-
tion between the meta-analysis and the combined analysis
(Figure S4) is evidence that linkage signals are of genetic origin.
Permutations
Permutation analysis is a useful approach for developing a
threshold that allows for nonindependence between multiple
tests.32 In this instance, we performed permutations for each
trait to generate thresholds to demonstrate that LOD scores from
the linkage analysis were more extreme than expected under the
null model of no genetic variation. For each permutation, pairwise
elements of the arrays of y1 and y2 were shuffled together, such
that the pairs of sibling phenotypes remained the same but no
longer corresponded to their IBD values. Then the entire linkage
analysis was performed with the permuted phenotypes, where
we no longer expected a biological link between genotype and
phenotype. This was performed 500 times for each trait.The AmericanSimulations
The outcome of the linkage analysis showed that there were LOD
scores exceeding traditional thresholds, as well as elevated LOD
scores across the genome. We performed simulations to under-
stand what kind of genetic architecture might manifest such a
result, whereby we used the genotypes used for calculating IBD
in the 20,240 siblings to simulate phenotypes representative of a
range of different architectures.
By changing the distribution of effects of common SNPs across
the genome, we generated different models. The simulations were
performed with all LD-pruned SNPs. Phenotypes were simulated
such that every SNP had a background effect sampled from either
distribution A, bA  NðmA;s2AÞ, or distribution B, bB  NðmB;s2BÞ.
For example, using this framework, if we were to simulate one
quantitative trait locus (QTL) per chromosome, then sA ¼ 0 and
sB ¼ 1, where one SNP is selected at random from each chromo-
some to be a QTL and has an effect sampled from distribution B.
For simulating a uniform polygenic effect, sA ¼ 1 and sB ¼ 0
such that each SNP has an effect. For simulating clustering of
effects, sA ¼ 0 and sB ¼ 1, and SNPs falling under distribution B
are chosen such that there are on average p cM between regions
for an effect drawn from distribution B and each region is q cM
in length. In this case, p ¼ 50 and q ¼ 5 (results of the simulations
are insensitive to the values chosen for parameters p and q [data
not shown]). An example of the distribution of SNP effects can
be seen in Figure S5. From the n3m dimensional matrix X, where
n is the number of individuals, m is the number of SNPs with an
effect, and each element Xij˛f0;1;2g represents the number of
minor alleles for individual i at SNP j, genetic scores were produced
for each individual i as
Gi ¼
X
bjXij:
The rare-effect models assumed that a single SNP was respon-
sible for the entire genetic variance within a family without occur-
ring in any other individuals in the population. Thus, for each
SNP, EðVGÞ ¼ h2=20;240. For simulating a uniform polygenic
model, a SNP j was chosen at random from the panel of ~20,000
SNPs for each of the 20,240 QISPs, and thus for an individual in
QISP i, his or her genetic score was defined simply as
Gi ¼ bi

Xi j Xj

sj:
For simulating a rare model with clustered genetic effects, SNPs
across the genome were sampled with nonuniform probabilities,
such that there were on average p cM between regions with length
q cM and these regions were given a 103 higher probability of
being sampled than any other regions. In this case, the values
were set to p ¼ 50 and q ¼ 5.
Genetic scores were generated within cohorts, and then final
phenotypes were produced after individuals from all cohorts
were combined. Nongenetic variance was simulated by the sam-
pling of ei  Nð0;VEÞ, where VE ¼ ðVG=h2Þ  VG.
For each model detailed above, simulations were performed
for h2 ¼ f0:42;0:69g. Simulations were performed for each of the
five cohorts and for the combined sample. Each model 3 h2 3 n
combination was repeated 500 times.A Note on Within-Family Analysis
Full details on the use of within-family analysis and its advantages
are outlined elsewhere,17,33 but a brief explanation follows. Given
that siblings are phenotypically correlated, one can ask, ‘‘Of theJournal of Human Genetics 93, 865–875, November 7, 2013 867
phenotypic similarity of two siblings, what proportion is attrib-
uted to the actual genomic proportion that they share by
descent’’? If a trait is heritable, then sibling pairs who have
higher-than-average genome-wide IBD will be phenotypically
more similar to each other. This is in essence equivalent to a link-
age analysis, but in this case we use genome-wide IBD instead of
IBD at a particular locus. We obtain a realized estimate of the total
amount of genetic similarity between siblings through direct
calculation of genome-wide IBD. Thus, in our ACE model, the
phenotypic similarity between siblings is partitioned into a pro-
portion of this covariance that is captured by the realized
genome-wide IBD between siblings (in the A component) and a
proportion that is not (C). In the extreme case that none of the sib-
ling phenotypic correlation can be explained by genome sharing
by descent, the A component would be zero and the C component
would reflect the observed phenotypic similarity. Conversely, if all
phenotypic correlation between siblings can be explained by how
much of their genome is shared by descent, then the C component
would be zero.
The only information that can contribute to the A component is
the realized genome-wide IBD between siblings, and because this
is simply determined by random recombination events at meiosis,
it is immune to confounding from population stratification.
Unlike other experimental designs, this approach requires no
assumptions regarding the common environmental structure of
complex pedigrees, and cohort-specific effects will be uncorrelated
with realized genome-wide IBD estimates. We performed two sim-
ulations to demonstrate this.
The purpose of the first simulation was to demonstrate that, un-
like association studies, within-family linkage analysis is immune
to population stratification. We simulated an extreme case of
population stratification in 20,000 QISPs from our five different
cohorts; h2 was set to 0 (no genetic effects), sibling correlation
was set to r ¼ 0.3, and a large cohort effect was simulated, which
explained 20% of phenotypic variance. We then performed
genome-wide linkage analysis as previously described. In associa-
tion studies, any ancestry-informative loci between cohorts would
be correlated with the cohort effect, leading to spurious associa-
tion signals and therefore a genomic-inflation factor (also known
as a genomic-control [GC] factor, lGC) significantly greater than 1.
However, because the cohort effect was uncorrelated with the
sibling IBD estimate, we observed no genomic inflation with the
within-family linkage design (100 replicates, mean(lGC) ¼ 1.02,
SE(lGC) ¼ 0.015, p ¼ 0.11, Figure S6).
The purpose of the second simulation was to demonstrate that
genetic heterogeneity between cohorts does not lead to biased
heritability estimates, nor does it lead to genomic inflation in a
within-family linkage analysis. Using 20,000 QISPs from five
different cohorts and ~20,000 LD-pruned SNPs, we simulated phe-
notypes such that each genetic effect was present in only one
cohort. To do this, we constructed the phenotypes by simulating
genetic effects at every SNP on chromosomes 1, 6, 11, 16, and
21 for individuals in the Framingham cohort, on chromosomes
2, 7, 12, 17, and 22 for the TWINGENE cohort, on chromosomes
3, 8, 13, and 18 for the TwinsUK cohort, on chromosomes 4, 9, 14,
and 19 for the Netherlands Twin Registry cohort, and on chromo-
somes 5, 10, 15, and 20 for the QIMR cohort. Genetic effects were
then scaled such that the phenotypes for each cohort had the
same heritability. This simulation represents the most extreme
form of genetic heterogeneity through genotype-cohort interac-
tion. Empirical heritability estimates of the simulated phenotypes
were obtained for 100 replicates for each simulated value of h2 ¼868 The American Journal of Human Genetics 93, 865–875, Novemb{0, 0.25, 0.5, 0.75, 1}. We observed unbiased estimates from these
simulations (Figure S7), as expected from a within-family design.
We also performed a linkage analysis for each simulated pheno-
type for each individual cohort and also for the cohorts combined.
Because there was no overlap of genetic effects between cohorts,
combining the data did not lead to increased genomic inflation
(Figure S8).
Despite its advantages for genetic analysis, it is important to note
that themaindrawbackofusing awithin-familydesign is its depen-
dence on very large sample sizes. This is because the SD of IBD
sharing is relatively small (e.g., ~0.037 for full siblings), and there-
fore large sample sizes are required for obtaining precise estimates.Results
Heritability Estimates for Height and BMI
Theory predicts that the expected proportion of alleles
shared identically by descent between siblings has a
mean of 0.5 and a SD of 0.039.17 We used ~20,000 SNPs
in linkage equilibrium to estimate IBD for 20,240 sibling
pairs from 9,577 nuclear families and obtained a SD of
0.037 (Figure S9). Because there is variation around the
expected value of 0.5, we could relate the proportion of
phenotypic similarity to the amount of genetic similarity
between siblings. We partitioned phenotypic variance of
BMI and height in additive genetic (A), common environ-
ment (C), and specific environment (E) variance compo-
nents to apportion phenotypic variance into genetic and
nongenetic causes. Considering that the variance for
BMI is larger in females than in males, we adjusted BMI
for a number of covariates (Table S2) in two gender groups
separately. Height was also adjusted for the covariates in
Table S2. Heritability was then estimated with REML,28
giving h2 ¼ 0.42 (SE 0.17) for BMI and 0.69 (SE 0.14) for
height (Table 1). Because age of measurement has a signif-
icant effect on BMI, the inclusion of siblings who were
measured at different ages might have reduced the herita-
bility estimate because they had a lower correlation
(Figure S10). We calculated the heritability for BMI on
17,039 QISPs who were measured within 10 years of
each other, resulting in h2 ¼ 0.35 (SE 0.18), demonstrating
that a possible age by genotype interaction does not cause
a deflation of h2.
Under a polygenic model of genetic architecture, we
expect the heritability contribution of a chromosome to
be proportional to its size.7,33 We quantified this by parti-
tioning the genetic variation, such that for each chro-
mosome, a variance component was composed from the
respective chromosome-wide coefficients of IBD sharing.
Figure S11 shows a positive relationship between chromo-
some size and genetic variance for height (r ¼ 0.38, p ¼
0.049) and BMI (r ¼ 0.08, p ¼ 0.469). The lack of statis-
tical significance for BMI is expected even under the
assumption that the association is real because a lower
heritability combined with larger sampling variance
of IBD coefficients for individual chromosomes entails
larger SEs.17er 7, 2013
Table 1. Summary of Estimates of BMI and Height Heritabilities from Realized Relationships for All Cohorts
Cohort QISPs r h2 (SE) c2 (SE) ra h2 (SE)b c2 (SE)c
QIMR 9,585 0.26 0.76 (0.20) 0.00 (0.10) 0.39 0.80 (0.22) 0.00 (0.10)
Framingham Heart study 4,607 0.30 0.00 (0.34) 0.27 (0.17) 0.47 0.72 (0.28) 0.10 (0.14)
TWINGENE 2,722 0.24 0.00 (0.47) 0.24 (0.24) 0.50 0.75 (0.35) 0.12 (0.18)
Netherlands Twin Registry 1,819 0.37 0.78 (0.47) 0.00 (0.23) 0.48 0.00 (0.42) 0.49 (0.22)
TwinsUK 1,507 0.41 0.31 (0.55) 0.25 (0.28) 0.54 0.56 (0.46) 0.26 (0.23)
Total 20,240 0.29 0.42 (0.17) 0.10 (0.08) 0.44 0.69 (0.14) 0.08 (0.07)
aCorrelation between phenotypes of QISPs after adjustment for fixed effects.
bHeritability estimates.
cProportion of the phenotypic variance attributed to common environmental variance.Polygenic Variation Causes Genomic Inflation in
Linkage Studies
Using these data, we were able to perform a linkage study
on both height and BMI.We constructed quantile-quantile
(Q-Q) plots of the test statistics for BMI and height and
observed increasing genomic-inflation factors (lGC) as
sample size increased (Figure 1, Figure 2, and Figure S12).
For the combined analysis, lGC ¼ 1.65 and 2.18 for BMI
and height, respectively. The lower inflation of test statis-
tics for BMI than for height is consistent with the fact
that BMI has a lower heritability. The inflation of test sta-
tistics in population-based studies such as GWASs could
arise from either truly associated variants or population
stratification.34 However, because within-family analysis
depends only on the degree of genetic sharing among sib-
lings, all signals from this linkage analysis must necessarily
be of genetic origin. We also observed that the linkage re-
sults from the combined data set shown here were consis-
tent with a meta-analysis performed on separate linkage
analyses of the five independent cohorts (Figure S4), rulingFigure 1. Q-Q Plots of Linkage Analyses
For each cohort (left five panels), as well as the combined data set an
Q-Q plots were produced for both BMI (top) and height (bottom) to d
expectation (x ¼ y line). 95% confidence intervals are shaded in gray
are pruned to be 20 cM apart for reducing correlations between test
cohorts are TwinsUK, Netherlands Twin Registry, TWINGENE, Frami
from the combined analysis, and the seventh panel represents the m
The Americanout variance heterogeneity between cohorts as a source of
test-statistic inflation.
To explore the possible genetic architecture behind this
genomic inflation, we used the genetic data from the
20,240 QISPs to simulate phenotypes by using different
underlying models of genetic architecture. Polygenic
models of evenly distributed variants or clustered variants,
as well as an oligogenic model (one QTL per chromosome),
were tested and generated with the use of either common
or rare variants (Figure S5).We recorded twomeasurements
per simulation, the proportion of loci with heritability
estimates greater than zero, Pðh2m > 0Þ, and the maximum
LOD score from each simulation. Under the null hypothe-
sis of no genetic variation, we expect Pðh2m > 0Þ ¼ 0:5
because the sampling variance of h2m estimates about zero
is symmetric. Our original linkage scan gave results of
0.61 (empirical SE ¼ 0.04, p ¼ 0.006) for BMI and 0.68
(SE ¼ 0.04, p ¼ 1.6 3 105) for height (Figure 2 and
Figure S13). The results from the simulation study, shown
in Figure 3, demonstrate that these values are consistentd the p values from the meta-analysis (the two right-most panels),
emonstrate overall genomic inflation as being a departure from the
, and GC values for each cell represent genomic inflation. Markers
s (for Q-Q plots on all markers, see Figure S12). From left to right,
ngham, and QIMR. The sixth panel (n ¼ 20,240) shows the results
eta-analysis of all five cohorts.
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Figure 2. Proportion of Markers with Positive Heritability Estimates Pðh2m > 0Þ
For each cohort (five bars to the left) and for the combined sample set (bar furthest to the right), an independent permutation analysis
was performed such that the entire family of tests was rerun with QISP phenotypes randomly relabeled from QISP genomic IBD scores.
Thus, each box-and-whisker plot represents the distribution of Pðh2m > 0Þ values from the 100 permutations per cohort; red points
represent the Pðh2m > 0Þ achieved in the true linkage scans.with expectations from polygenic models when sample
size gets sufficiently large. We observed no difference
between linkage results for different simulated polygenic
models and those from the actual linkage analysis on
BMI and height.
Polygenic Variation Creates the Illusion of Large
Effects in Linkage Studies
QTLs discovered for complex traits through linkage studies
have a long history of poor replication rates in indepen-
dent samples,18 and this might provide evidence of an
underlying polygenic architecture. Using the traditional
genome-wide threshold of LOD ¼ 3.0, our linkage analysis
detected one significant region for BMI (chromosome 20)
and two for height (chromosomes 5 and 15), but these870 The American Journal of Human Genetics 93, 865–875, Novembwere not significant at the more stringent threshold of
LOD ¼ 3.335 (Figure 4 and Figure S14). We confirmed
by permutation analysis32 that these linkage peaks were
genome-wide significant when tested against the null
model of no genetic variation anywhere in the genome
(p < 0.05) (Figure S15). Using the polygenic simulation
results, we then derived empirical significance thresholds
under the null model of underlying polygenic variation
(Figure S16). At these thresholds, the linkage peaks were
not significant at the experiment-wide level (p ¼ 0.21 for
BMI and 0.18 for height, Figure 4).
Association studies have not previously reported sig-
nificant signals on chromosome 20 for BMI,36 whereas
numerous reports of weak signals from linkage studies
have implicated almost the entire genome37 (includinger 7, 2013
Figure 3. Simulations of Genetic Effect Models
Expected results for various polygenic models are compared to observed results from true linkage analyses. MaximumLOD scores (y axis)
from linkage scans are plotted against Pðh2m > 0Þ (x axis). Rows of panels correspond to sample sizes, representing different cohort sizes
(top five rows) and the combined data set (bottom row). Columns of panels correspond to simulated h2; the left column represents BMI,
and the right column represents height. Each model 3 sample size 3 heritability combination was replicated 100 times, and error bars
represent 95% confidence intervals. Genetic models are as follows: Null, no genetic effects; C1, oligogenic where a single common QTL
exists per chromosome; C2, polygenic with common SNPs uniformly distributed throughout the genome; C3, polygenic with common
SNPs clustering across the genome; R1, polygenic with rare SNPs uniformly distributed throughout the genome; and R2, polygenic with
rare SNPs clustering across the genome. It is shown that different polygenic architectures have nearly identical properties in linkage anal-
ysis and that they are consistent with the results for BMI and height.chromosome 2038) to have some involvement (Figure S17).
Our simulations indicate that under a polygenic model of
genetic architecture, where no large effect exists, we expect
to find signals of LOD > 3.3 at experiment-wide error
levels of a ¼ 0.12 and a ¼ 0.20 for BMI and height, respec-
tively. Moreover, at the more traditionally used threshold
of LOD ¼ 3.0, we expect error levels of a ¼ 0.20 and a ¼
0.32 for BMI and height, respectively. This is evidence
that the observation of seemingly large effects in linkage
studies is actually more likely to be a property of a highly
polygenic underlying architecture.The AmericanDiscussion
How we design future studies to uncover genetic variants
will depend on the underlying genetic architecture of the
trait in question.39 There is mounting evidence that
many of the traits that we call complex are highly poly-
genic. One example is from GWASs, where robustly associ-
ated common variants are increasingly found for BMI and
height as the sample size increases, suggesting that there
exist many variants of small effect for these traits.15,16 It
is possible to use results from such studies to estimate theJournal of Human Genetics 93, 865–875, November 7, 2013 871
Figure 4. Linkage Analysis for BMI and Height
LOD scores for BMI across all autosomes are shown on the top row, and height is shown on the bottom row. The traditional threshold of
LOD ¼ 3.3 is depicted by solid lines, and the more stringent empirical threshold based on simulations of polygenic models is shown by
dotted lines (a ¼ 0.05, see Figure S16). Blue points represent GWAS hits from the GIANT study (different shades of blue correspond to
different log10 p values). There is no correlation between linkage signals and GWAS signals (Figure S18).total number of variants contributing to the trait’s genetic
variance.40–42 Another line of evidence comes from
sequencing studies, where it has been shown that an in-
crease in de novo mutations leads to an increased risk of
schizophrenia and autism, indicating a large mutational
target across the genome.43,44 In this study, we present
evidence of polygenicity from the observed genome-wide
inflation of BMI and height test statistics that are free
from confounding.
Heritability estimates for height are relatively consistent
across studies and between different experimental designs.
However, the estimates of heritability for BMI vary widely;
on average, they are reported to be 0.75 in twin-based
studies and 0.46 in non-twin pedigree studies.11 All
pedigree designs rely on inference from the resemblance
between relatives and therefore depend on modeling
assumptions,45–47 such as the extent of shared environ-
mental factors between different types of relatives. Here,
we used a method that utilizes the realized sharing of
genetic variation between siblings to avoid any depen-
dence on modeling assumptions17 to estimate heritability
of BMI and height from 20,240 QISPs at 0.42 (SE ¼ 0.17,
p ¼ 0.01) and 0.69 (SE ¼ 0.14, p ¼ 6 3 107), respectively.
A recent study using IBD estimates derived from long-
range phased genotype data in an extended genealogy
also reported estimates of h2 ¼ 0.42 for BMI and 0.69 for
height, further supporting that h2 for BMI and height
was likely to be overestimated in previous twin and family
studies.48
From these results, we can make some inference on the
relative contribution of rare and common variants to
BMI. ‘‘Chip heritability’’ estimates ðh2c Þ, the proportion of
phenotypic variance explained by common SNPs, are typi-
cally much lower in BMI than in height. The discrepancy
between h2c and h
2 is likely to arise when causal variants
and observed SNPs are in insufficient LD, hypothesized
to be caused in part by the difference in allele-frequency872 The American Journal of Human Genetics 93, 865–875, Novembdistributions between the causal variants and the observed
SNPs.8 For example, from our estimate of heritability for
height, the ratio h2c =h
2 ¼ 0:46=0:69 ¼ 0:67 suggests that
rare variants contribute relatively little to the genetic
variance for height,8 given that only one-third of heritabil-
ity is missing. However, h2c ¼ 0:17 7 for BMI, and because
previous h2 estimates have been variable,11,13 the variance
proportion that is said to be missing is not easily deter-
mined. Under the assumption that the heritability of
BMI is approximately the same as that of height, then a
substantial proportion ð1 ð0:17=0:69Þ ¼ 0:75Þ of the
genetic variance is not captured by common SNPs. How-
ever, in this study we report an estimate of h2 ¼ 0:42 for
BMI, which falls at the lower end of the range of previous
estimates. This suggests that the role of rare variants might
be of lesser importance for BMI than was previously sug-
gested7 (i.e., ð0:17=0:42Þ ¼ 0:40 of the variance is captured
by common SNPs). An important consequence of this
finding is that association studies for BMI are likely to
have lower power to identify causal variants than are
equally sized studies for height where the heritability is
higher. Recent results from large-scale meta-analyses sup-
port this conclusion (32 associations in BMI versus 180
in height in similarly sized studies49).
Our study also provides an interpretation of the past two
decades of linkage studies. Linkage analysis has a long his-
tory of reporting significant signals (given traditional
thresholds of LOD¼ 3.050 or 3.335) that mostly fail to repli-
cate in independent studies.18,37,51 This might be caused
by a variety of phenomena, for example, rare variants
with large effects that are unique to a single family will
not be replicated in other cohorts.39 However, we have
demonstrated that when there is no such large effect,
one can still observe significant signals given a polygenic
model of genetic architecture. Thus, a parsimonious expla-
nation for linkage signals that cannot be replicated is that
the thresholds cited above are not sufficiently stringenter 7, 2013
because they assume a null model of no genetic effects.52
One way that nonreplicating linkage signals could arise
from a highly polygenic architecture is that through
random sampling, a chromosomal region can have multi-
ple alleles of small effect shared identically by descent
across families on one sample by chance, and this stochas-
tic occurrence is unlikely to be repeated in an independent
sample. Through our simulation studies, we have shown
that under the null model of genome-wide polygenic
variation, the traditionally used thresholds are too low to
detect a region with a large effect and should be set depen-
dent upon trait heritability (e.g., LOD ¼ 3.7 for h2 ¼ 0.42
and LOD ¼ 4.1 for h2 ¼ 0.69). We also suggest that using
the term ‘‘false positive’’ is not strictly accurate when dis-
cussing previously reported signals that failed to replicate
because they are indeed likely to be caused by genetic vari-
ation. However, they are unlikely to signify the presence of
a genomic region with a single large effect, which is often
the goal of linkage analysis.
In summary, using results from our large SNP-based link-
age study to date, we have provided evidence that BMI and
height are highly polygenic, that heritability of BMI might
have been previously overestimated, and that the failure
of most linkage studies to replicate or lead to identified
causal variants can be reconciled by the polygenic nature
of complex traits.Supplemental Data
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